Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intralesional Bevacizumab for Non-pedunculated Keloids
NCT01408953Phase 2Terminated
- Start
- Feb 2012
- Primary completion
- Nov 2012
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in keloid. Started Feb 2012; status: terminated.
02
Drugs
bevacizumab
03
Conditions
keloid
Beyond the preview
Go deeper on NCT01408953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01408953.